NTJ-31264-15740
2 vaccinations
3 coded responses
14 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2021-05-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-11
Dose 1 — Pfizer-BioNTech
-
2021-05-31
Registered in v-safe
- 2021-05-31
-
2021-06-01
Dose 2 — Pfizer-BioNTech
- 2021-06-01
-
2021-06-02
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11
- 2021-06-03
- 2021-06-04
- 2021-06-07
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-06-29
-
2021-07-06
Survey response — day 35, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11
- 2021-07-13
- 2021-09-01
-
2021-12-01
Survey response — 6 months, dose 2MedDRA: Malaise, Nasal congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-11 | Pfizer-BioNTech | |
| 2 | 2021-06-01 | Pfizer-BioNTech |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release